📰 Biocon Park News
Biocon Park News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Biocon Park. Real-time updates on events, politics, business and more.
November 30, 2023
Weve got a huge track record and success in bringing several biosimilars to the market.
May 1, 2023
Based on the OI percentage, 83 stocks, including Aarti Industries, Syngene International, IndiaMART InterMESH, Laurus Labs, and IDFC First Bank, saw long build-ups.
April 28, 2023
Biocon Biologics integrated, multi-product, monoclonal antibodies Drug Substance manufacturing facility at Biocon Park, Bengaluru, has received a Certificate of GMP Compliance.
April 18, 2023
Syngene Intl Share Price: Find the latest news on Syngene Intl Stock Price. Get all the information on Syngene Intl with historic price charts for NSE / BSE. Experts & Broker view also get the Syngene Intl Ltd. buy/sell tips detailed news, announcements, Forecasts, Analysts, Valuation, Earning forecasts, Estimates, Recommendations, Analysts Ratings, financial report, company information, annual report, balance sheet, profit & loss account, results and more.
July 7, 2022
Bengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd. has announced that the company has received an EU GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its...
July 6, 2022
This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.
July 5, 2022
The EU Good Manufacturing Practices (GMP) accreditation is offered to pharmaceutical manufacturers who adhere to a minimal standard in their production practices.
May 3, 2022
Read more about Ireland regulator reports manufacturing deficiency at Biocon's Bengaluru plant on Devdiscourse
May 3, 2022
Biotechnology major Biocon Biologics on Tuesday said Ireland's health regulator has reported some deficiencies in the manufacturing process at the company's plant in Bengaluru. The Health Products Regulatory Authority (HPRA), Ireland, conducted a GMP (Good Manufacturing Practice) inspection of one of Biocon Biologics' new monoclonal antibody drug substance manufacturing